Clinical Trials Sponsored by Institut Pasteur, Paris France

Total 320 results

Assistance Publique - Hôpitaux de Paris
Institut Pasteur, Paris France

Completed

PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis (OPTIFIL)

Aspergillosis and Haematological Malignancy

France
Institut Pasteur
Agence de Médecine Préventive, France; Institut Pasteur de Madagascar; Institut...

Completed

Pertussis Immunization Programs in Low Income Countries (PERILIC)

Bordetella Pertussis, Whooping Cough

Cambodia, Madagascar, Togo
Institut Pasteur
National Research Agency, France

Completed

Milieu Intérieur Collection - Genetic & Environmental Determinants Of Immune Phenotype Variance (MI)

Healthy Subjects | Individuality
Assistance Publique - Hôpitaux de Paris
Institut Pasteur; French National sanitory

Completed

National Study on Listeriosis and Listeria (MONALISA)

Central Nervous System Infections | Pregnancy Complications | Infectious | Septicemia | Listeriosis | Sepsis; Listeria Monocytogenes

France
Assistance Publique - Hôpitaux de Paris
Pasteur Institute of Paris

Recruiting

Analysis of the Nasal Mucosal Immune Response in HIV Infection (HYSOPE)

HIV Infections

France
Delafontaine Hospital
Unity Health Toronto; Saint-Louis Hospital, Paris, France; Institut Pasteur; Jacques...

Unknown

Bacterial Infection Diagnosis Using Blood DNA

Sepsis | Infection

France
Assistance Publique - Hôpitaux de Paris
Institut Pasteur

Completed

Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN) (OPIODYN)

Burning Mouth Syndrome
Assistance Publique - Hôpitaux de Paris
Institut Pasteur

Completed

Prolactin Receptor and Breast Diseases (Prolacsein)

Breast Cancer | Benign Breast Disease

France
Institut Pasteur
Assistance Publique - Hôpitaux de Paris

Recruiting

Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer (PREGASIGN#1)

Gastric Cancer | Gastric Precancerous Condition | Gastric Lesion

France
Assistance Publique - Hôpitaux de Paris
Institut Pasteur

Recruiting

Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room (MEDIREP)

Hypersensitivity, Immediate | Peri-operative Injury | Antibody Hypersensitivity | Antibiotic Allergy

France
Institut Pasteur
Assistance Publique - Hôpitaux de Paris

Recruiting

Study of Viral Transduction of Human Auditory Sensory Cells for the Development of Gene Therapy (TREATGENE)

Hearing Loss, Sensorineural

France
Assistance Publique - Hôpitaux de Paris
Institut Pasteur

Withdrawn

Immune Response of Asymptomatic EHPAD Employees Infected With COVID-19 (SERASYMPTO)

COVID-19

France
Assistance Publique - Hôpitaux de Paris
Institut Pasteur

Completed

Monoclonal Antibodies in Clostridium Difficile Infection (IgAClostridium)

Clostridium Infection

France
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Institut...

Completed

Neurological Consequences of Perinatal Listeriosis Infection (MONALISABABY)

Perinatal Listeriosis

France
Groupe Hospitalier Paris Saint Joseph
Assistance Publique - Hôpitaux de Paris; Institut Pasteur; BioMérieux

Completed

SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICU (Captain)

Sepsis | Septic Shock | Severe Sepsis | SIRS

France
Institut National de la Santé Et de la Recherche...
Assistance Publique - Hôpitaux de Paris; Institut Pasteur

Completed

Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage (FluBAL)

Influenza | Acute Respiratory Distress Syndrome | Acute Lung Injury

France
Assistance Publique - Hôpitaux de Paris
Institut Pasteur; Pathogen Discovery Laboratory

Recruiting

Metatranscriptomic Next Generation Sequencing in First Trimester Trophoblast With Increased Fetal Nuchal Translucency (METAHCN) (METAHCN)

Increased Nuchal Translucency in the First Trimester of Pregnancy

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France; Université de...

Recruiting

Molecular Signature From Tumor to Lymph Nodes (N2-3S)

Lung Cancer | Stage IIIA-cN2 | Operated With Curative Intent | Primary Tumor Tissue Available | Node Tumor Tissue Available

France
University Hospital, Rouen
Institut Pasteur; Direction Générale de la Santé, France

Completed

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC) (Exten Effivac)

Neisseria Meningitidis

France
Institut Mutualiste Montsouris
Fondation de l'Avenir; Paris cite university, 75006 Paris, France

Completed

Contribution of 3D Printing in Anatomical Lung Segmentectomies. (3DiLUNG)

Thoracic Surgery

France
Institut de Myologie, France
Assistance Publique - Hôpitaux de Paris

Completed

Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis (IBMan)

Inclusion Body Myositis

France
Institut de Myologie, France
Assistance Publique - Hôpitaux de Paris

Completed

Pregnancy Outcomes in Congenital Myasthenie Syndrome (POCoMS)

Congenital Myasthenic Syndrome
University Hospital, Rouen
Institut Pasteur; Direction Générale de la Santé, France; Dieppe

Completed

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac) (Exten MenbVac)

Vaccination With MenbVac

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Not yet recruiting

Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit (COLOSAVE)

Colorectal Cancer

France
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France

Recruiting

Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE) (COMETE-CARE)

Cancer | Adrenal

France
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France

Completed

Elderly CAncer Patient: Qualitative and Quantitative Factors of Inclusion Failure in Clinical Trials (Quali-SAGE)

Cancer | Elderly | Ethnographic Interview | Social Representation of Being Aged | Reasons of Non-participation in Clinical Trials | Qualitative Method

France
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France

Unknown

Financial Incentive for Smoking Cessation in Pregnancy (FISCP)

Smoking | Pregnancy

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Completed

Smoking Cessation for Patients With Acute Coronary Syndrome (ACS) (PATPAC)

Smoking | Acute Coronary Syndrome

France
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France

Not yet recruiting

Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer (HRPCa-II) (HRPCa-II)

Prostate Cancer
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaborators

Completed

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 (PED-COVID)

COVID-19 Infection

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Terminated

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (PROVE)

Venous Thromboembolism | Lung Neoplasm

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Unknown

Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism (aXa)

Neoplasms | Venous Thromboembolism

France
University Hospital, Montpellier
CHU Marius Lacroix, Lille, FRANCE; CHU Gabriel Montpied, Clermont Ferrand,... and other collaborators

Recruiting

Psychoeducation for Suicidal Behavior (PEPSUI)

Suicide, Attempted | Suicidal Behavior

France
University Hospital, Lille
Institut Pasteur de Lille; University of Lille Nord de France

Recruiting

A Clinico-biological Database of Lung Cancers (Bio-lung)

Lung Cancer

France
Institut Pasteur
Assistance Publique - Hôpitaux de Paris; Université de Nantes; IPSOS; Institut... and other collaborators

Completed

Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19 (ComCor)

Covid19

France
University of Oxford
KEMRI-Wellcome Trust Collaborative Research Program; Institut Pasteur; MRC/UVRI... and other collaborators

Completed

Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine (NIFTY)

Yellow Fever

Kenya, Uganda
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaborators

Completed

Efficacy Safety Study of Flu Vaccine in Immunodepression Patients (MICIVAX)

Inflammatory Bowel Disease (IBD)

France
Groupe Hospitalier Paris Saint Joseph
Institut Pasteur; Agency for Science, Technology and Research

Completed

Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis (CASPASEs)

Severe Sepsis

France
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Recruiting

Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer (PEACE-4)

Prostate Cancer

France, Switzerland
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Terminated

Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction (VERITAS)

Very High Risk Neuroblastoma

Italy, Austria, France, Netherlands, Spain
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Completed

Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP (GEFCAPI04)

Neoplasms, Unknown Primary

Denmark, France, Netherlands
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Completed

Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions (NOMAT01)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Unknown

Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients (Estimabl)

Thyroid Cancer

France
Institut National de la Santé Et de la Recherche...
University Hospital, Toulouse; Association des Traumatisés du Crane et de la...

Completed

Longitudinal Study of the Default-mode Network Connectivity in Brain Injured Patients Recovering From Coma (ACI-Coma)

Coma

France
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Recruiting

Two Chemotherapy Regimens Plus or Minus Bevacizumab (BETTER2)

Pancreatic Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Completed

Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer (IRCIS)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Recruiting

AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy (NANOCOL)

Gynecologic Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Recruiting

European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors (ESMART)

Pediatric Cancer

Italy, France, Denmark, Germany, Netherlands, Spain, United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Active, not recruiting

Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma (SURVEILL'ORL)

Head and Neck Squamous Cell Carcinoma

France
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Suspended

Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases (PACHA-01)

Colorectal Cancer

France

Clinical Trials Sponsored by Institut Pasteur, Paris France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations